Growth Hormone (GH) and Cardiovascular System.

作者: Diego Caicedo , Oscar Díaz , Pablo Devesa , Jesús Devesa

DOI: 10.3390/IJMS19010290

关键词:

摘要: This review describes the positive effects of growth hormone (GH) on cardiovascular system. We analyze why vascular endothelium is a real internal secretion gland, whose inflammation first step for developing atherosclerosis, as well mechanisms by which GH acts vessels improving oxidative stress imbalance and endothelial dysfunction. also report how coronary arterial disease heart failure, peripheral disease, inducing neovascularization process that finally increases flow in ischemic tissues. include some preliminary data from trial or placebo given to elderly people suffering critical limb ischemia, showing benefits plasma markers inflammation, safety administration during short periods time, even diabetic patients. Klotho strongly related GH, inducing, after being released damaged endothelium, pituitary most likely repair injury show can help wound healing increasing blood neurotrophic factors. In summary, we postulate short-term could be useful treat diseases.

参考文章(254)
Christopher Heeschen, Stefanie Dimmeler, Christian W Hamm, Stephan Fichtlscherer, Maarten L Simoons, Andreas M Zeiher, CAPTURE Study Investigators, Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. Journal of the American College of Cardiology. ,vol. 45, pp. 229- 237 ,(2005) , 10.1016/J.JACC.2004.09.060
Elizabeth A. Davis, Sui-Aun Soong, Geoffrey C. Byrne, Timothy W. Jones, Growth hormone and premature atherosclerosis in childhood obesity. Journal of Pediatric Endocrinology and Metabolism. ,vol. 19, pp. 455- 465 ,(2006) , 10.1515/JPEM.2006.19.4.455
James A. de Lemos, Rebecca Vigen, Keeping the genie in the bottle: growth hormone and cardiovascular disease. Journal of the American College of Cardiology. ,vol. 64, pp. 1461- 1463 ,(2014) , 10.1016/J.JACC.2014.05.070
José Manuel Fragoso Lona, Julián Ramírez Bello, Angélica Barrios Rodas, Gilberto Vargas Alarcón, Mónica Martínez Sierra, El factor de necrosis tumoral alfa (TNF-alfa) en las enfermedades cardiovasculares: biología molecular y genética Gaceta Medica De Mexico. ,vol. 149, pp. 521- 530 ,(2013)
Ido Wolf, Daniel Stein, Shiri Shahmoon, Shimrit Ilana Ziv, Rina Hemi, Hannah Kanety, Tami Rubinek, Dalit Modan-Moses, Alteration in serum klotho levels in anorexia nervosa patients. Clinical Nutrition. ,vol. 35, pp. 958- 962 ,(2016) , 10.1016/J.CLNU.2015.07.013
Jean-Claude Tardif, Jean-François Tanguay, Scott R. Wright, Valérie Duchatelle, Thibaut Petroni, Jean C. Grégoire, Reda Ibrahim, Therese M. Heinonen, Stephen Robb, Olivier F. Bertrand, Daniel Cournoyer, Dominique Johnson, Jessica Mann, Marie-Claude Guertin, Philippe L. L'Allier, Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation Myocardial Infarction : Results of the SELECT-ACS Trial Journal of the American College of Cardiology. ,vol. 61, pp. 2048- 2055 ,(2013) , 10.1016/J.JACC.2013.03.003
Christin Carter-Su, Jessica Schwartz, Lawrence S. Argetsinger, Growth hormone signaling pathways. Growth Hormone & Igf Research. ,vol. 28, pp. 11- 15 ,(2016) , 10.1016/J.GHIR.2015.09.002
Erik Hallengren, Peter Almgren, Gunnar Engström, Bo Hedblad, Margaretha Persson, Jennifer Suhr, Andreas Bergmann, Olle Melander, Fasting Levels of High-Sensitivity Growth Hormone Predict Cardiovascular Morbidity and Mortality Journal of the American College of Cardiology. ,vol. 64, pp. 1452- 1460 ,(2014) , 10.1016/J.JACC.2014.03.063
Enlimomab Acute Stroke Trial Investigators, None, Use of anti-ICAM-1 therapy in ischemic stroke Results of the Enlimomab Acute Stroke Trial Neurology. ,vol. 57, pp. 1428- 1434 ,(2001) , 10.1212/WNL.57.8.1428
P C Heinrich, J V Castell, T Andus, Interleukin-6 and the acute phase response Biochemical Journal. ,vol. 265, pp. 621- 636 ,(1990) , 10.1042/BJ2650621